NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro by Roelofs, A, Russell, R, Ebetino, F, Shipman, C

The bisphosphonate-ester apornine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells by Roelofs, A, Hulley, P, Graham, R, Russell, G, Shipman, C

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro by Roelofs, A, Edwards, C, Russell, R, Rogers, M, Hulley, P

Bisphosphonates: Mechanisms of Action by Roelofs, A, Ebetino, F, Reszka, A, Russell, R, Rogers, M

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of p... by Roelofs, A, Hulley, P, Russell, R, Ebetino, F, Rogers, M

Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro by Roelofs, A, Hulley, P, Meijer, A, Croucher, P, Russell, R, Shipman, C

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. by Roelofs, A, Edwards, C, Russell, R, Ebetino, F, Rogers, M, Hulley, P

Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells. by Roelofs, A, Hulley, P, Russell, R, Ebetino, F, Rogers, M, Shipman, C

Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells. by Roelofs, A, Hulley, P, Meijer, A, Ebetino, F, Russell, R, Shipman, C

Dissociating the functional roles of arcuate fasciculus subtracts in speech production by Janssen, N, Kessels, RPC, Mars, RB, Llera, A, Beckmann, CF, Roelofs, A

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis. by Kashemirov, B, Bala, J, Chen, X, Ebetino, F, Xia, Z, Russell, R, Coxon, F, Roelofs, A, Rogers, M, McKenna, C

Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo by Roelofs, A, Boyde, A, Lundy, M, McKenna, C, Blazewska, K, Sun, S, Kashemirov, B, Russell, R, Ebetino, F, Rogers, M, Coxon, F

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo. by Roelofs, A, Stewart, C, Sun, S, Błażewska, K, Kashemirov, B, McKenna, C, Russell, R, Rogers, M, Lundy, M, Ebetino, F, Coxon, F

The Ability of Bisphosphonates and Their Analogues to Penetrate the Osteocyte Network is Dependent on Affinity for Bone by Roelofs, A, Boyde, A, Lundy, M, McKenna, C, Blazewska, K, Sun, S, Kashemirov, B, Duan, X, Russell, G, Khalid, A, Rogers, M, Ebetino, F

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes by Coxon, F, Bala, J, Kashemirov, B, Lundy, M, Chen, X, Xia, Z, Dunford, J, Russell, G, Roelofs, A, Rogers, M, McKenna, C, Ebetino, F

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes by Coxon, F, Bala, J, Kashemirov, B, Roelofs, A, Lundy, M, Chen, X, Xia, Z, Dunford, J, Russell, R, Rogers, M, McKenna, C, Ebetino, F

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo. by Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P